CN102228583A - Chinese herbal composition and application thereof to preparing antirheumatic and antalgesic medicines - Google Patents
Chinese herbal composition and application thereof to preparing antirheumatic and antalgesic medicines Download PDFInfo
- Publication number
- CN102228583A CN102228583A CN2011101769332A CN201110176933A CN102228583A CN 102228583 A CN102228583 A CN 102228583A CN 2011101769332 A CN2011101769332 A CN 2011101769332A CN 201110176933 A CN201110176933 A CN 201110176933A CN 102228583 A CN102228583 A CN 102228583A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- chinese medicine
- radix
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herbal composition capable of being used as antirheumatic and antalgesic medicines and application thereof. The Chinese herbal composition is prepared from the following raw materials in parts by weight: 5-20 parts of ligusticum wallichii, 5-20 parts of angelica, 5-20 parts of notoginseng, 5-30 parts of Poria cocos, 5-30 parts of fructus liquidambaris, 5-30 parts of atractylodes lancea, 5-30 parts of rhizoma cibotii, 5-40 parts of rheum forrestii, 5-20 parts of rhizoma alismatis, 5-25 parts of herba epimedii, 5-30 parts of selfheal, 5-25 parts of paniculate swallowwort root, 5-30 parts of radix clematidis and 5-25 parts of Scindapsus aure. The Chinese herbal composition has an excellent therapeutic effect on pains of limbs caused by cold and rheumatism; and clinical application for more than one year proves that more than 90 percent of more than 100 patients with rheumatalgia are healed within one month and no discomfort is caused during the taking of the medicine.
Description
Technical field
The present invention relates to a kind of to extremities joint because of being affected by the cold, rheumatism and the pain that causes has the Chinese medicine composition of therapeutic effect.
Background technology
Rheumatism is meant the class disease based on muscle, arthralgia.The traditional Chinese medical science thinks because exopathogen invasion and attack human bodies such as wind, cold, wet, heat, and the impatency passages through which vital energy circulates causes.Rheumatism refers to mainly invade joint, muscle, skeleton and periarticular soft tissue, as the disease at positions such as tendon, ligament, synovial bursa, fascia.Rheumatismal cardinal symptom shows as and haves a low fever, arthralgia is red and swollen.At present, the Therapeutic Method of rheumatism mainly contains surgical treatment, massotherapy, pharmacotherapy, treatments such as function nursing exercise and other therapy such as physics, rehabilitation, vocational training, psychology.An important branch of pharmacotherapy is Chinese traditional treatment.The maximum characteristics of Chinese traditional treatment disease are determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, and are integrally-regulated.Chinese traditional treatment rheumatism effect is better relatively, and Chinese medicine can also be by regulating the immunologic function of human body, mitigate the disease effectively, improve body constitution, reduce hormone and remove the danger that recurs in the process of subtracting, reduce the attack times and the outbreak order of severity, thereby can slow down even stop the process of disease effectively.For the rheumatisant, the main clinical manifestation current according to patient at first distinguished its characteristic of disease, is the deficiency and excess cold and heat, as true card, is migratory arthralgia, arthralgia due to cold, pyretic arthralgia or arthralgia chiefly caused by damp pathogen when distinguishing, and selects corresponding antirheumatic pain relieving medicaments again.
In the prior art, the characteristics that are used as the Chinese medicine composition of antirheumatic pain relieving medicaments are to use the wind dispelling of group, loose wind, dry and insect medicine, though have certain therapeutic effect, but also brought certain side effect simultaneously, for example insect medicine has bigger injury to people's Liver and kidney, and the safety in utilization of medicine is lower, and patient is easy to generate discomfort at period in a medicine.And concerning Liver and kidney is not good rheumatisant, then can not take these medicines fully.
Summary of the invention
Technical problem to be solved by this invention is the clothes the deficiencies in the prior art, and a kind of Chinese medicine composition is provided, its for extremities joint because of the rheumatism that is affected by the cold, rheumatism causes has good therapeutic effect, and can not damage people's liver, side effect is little.
For solving above technical problem, the following technical scheme of the present invention:
A kind of Chinese medicine composition, it is made by following bulk drugs compatibility: 5～20 parts of Rhizoma Chuanxiongs, 5～20 parts of Radix Angelicae Sinensis, 5～20 parts in Radix Notoginseng, 5～30 parts in Poria, 5～30 parts of Fructus Liquidambaris, 5～30 parts of Rhizoma Atractylodis, 5～30 parts of Rhizoma Cibotii, 5～40 parts of Radix Achyranthis Bidentatae, 5～20 parts of Rhizoma Alismatis, 5～25 parts of Herba Epimedii, withered luxuriant 5～30 parts of summer, 5～25 parts of the normal ministers in ancient times of Xu, 5～30 parts of Radix Clematidis, 5～25 parts of Scindapsus aureus.
Preferably, described Chinese medicine composition is made by following bulk drugs compatibility: 8～10 parts of Rhizoma Chuanxiongs, 8～10 parts of Radix Angelicae Sinensis, 8～10 parts in Radix Notoginseng, 10～20 parts in Poria, 10～15 parts of Fructus Liquidambaris, 10～15 parts of Rhizoma Atractylodis, 8～10 parts of Rhizoma Cibotii, 10～20 parts of Radix Achyranthis Bidentatae, 8～10 parts of Rhizoma Alismatis, 10～15 parts of Herba Epimedii, withered luxuriant 10～15 parts of summer, 8～12 parts of the normal ministers in ancient times of Xu, 10～15 parts of Radix Clematidis, 10～20 parts of Scindapsus aureus.
As a representative formulations of the present invention, described Chinese medicine composition is made by following bulk drugs compatibility: 9 parts of Rhizoma Chuanxiongs, 9 parts of Radix Angelicae Sinensis, 9 parts in Radix Notoginseng, 15 parts in Poria, 11 parts of Fructus Liquidambaris, 11 parts of Rhizoma Atractylodis, 9 parts of Rhizoma Cibotii, 14 parts of Radix Achyranthis Bidentatae, 9 parts of Rhizoma Alismatis, 12 parts of Herba Epimedii, withered luxuriant 12 parts of summer, 10 parts of the normal ministers in ancient times of Xu, 13 parts of Radix Clematidis, 15 parts of Scindapsus aureus.
Preferably, in the described crude drug, weight such as Rhizoma Chuanxiong, Radix Angelicae Sinensis, Radix Notoginseng, Rhizoma Alismatis and Rhizoma Cibotii are used.
The invention still further relates to the purposes, particularly antirheumatic pain relieving medicaments of above-mentioned Chinese medicine composition in the preparation antirheumatic pain relieving medicaments is the medicine that is used for extremity rheumatalgia.
The above-mentioned Chinese medicine composition of the present invention can be made into any pharmaceutically acceptable dosage form and takes for the people, for example decocts into to make capsule after medicinal liquid is taken or pulverized and take, and preferably makes capsule and takes.
Because the utilization of technique scheme, the present invention compared with prior art has following advantage:
Chinese medicine composition composition formula provided by the present invention is changed traditional treatment rheumatalgia medication characteristics, do not use the insect medicine that Liver and kidney is had injury, and select for use nontoxic suffering lead to the medical herbs of walking to wear reach stimulate the menstrual flow, active, damp eliminating, the purpose of blood-activating and qi-promoting, thus reach the treatment rheumatalgia effect.Because of being affected by the cold, rheumatism and the treatment of pain that causes have better effect Chinese medicine composition of the present invention for human limb.Show through more than a year clinical practice, among the 100 many cases extremity wind pain patient, rehabilitation in month more than 90%, and period in a medicine does not have any discomfort.
The specific embodiment
Famous traditional Chinese medical science Peng Zi benefit of the late Qing Dynasty has a penetrating argumentation to the relation of personal meridians and internal organs: " as electric wire, internal organs are especially as the bottle of accumulate through especially for the person 12; Wherein " warp " process is arranged again, through the meaning of pipe.Forming an integral part for meridians and internal organs.Mechanism of qi follows row in 12 warps, flows round without stopping, as ring for no reason.The disease of human body is that this gas is from sick ".The present application people sums up after deliberation, the wind and cold that human limb rheumatalgia is just extraneous, dampness has hurt meridians and has not hurt internal organs, wind and cold, dampness hurt sb.'s feelings 12 through all hindering, not only injure certain once.Cold coagulation is at meridians, wet the meridians path is obstructed, thus control extremity rheumatalgia need only damp eliminating, relaxing muscles and tendons and activating QI and blood in the collateral, promoting flow of QI and blood, the silt of dispelling, and do not need Liver and kidney is had the injury insect medicine, carminative with group.Based on this cognition, the inventor has proposed prescription of the present invention on big quantity research basis.
Related whole crude drug all are known in the present invention's prescription, and therefore, its source and processing method all are that those skilled in the art are known.The present invention mainly is these crude drug are carried out reasonable compatibility, and does not relate to the improvement to concrete certain or some crude drug itself or its processing method.
Below in conjunction with the representational embodiment of the present invention the present invention is further described.
Embodiment 1: the Chinese medicine composition according to present embodiment is formed by following bulk drugs compatibility: 9 parts of Rhizoma Chuanxiongs, 9 parts of Radix Angelicae Sinensis, 9 parts in Radix Notoginseng, 15 parts in Poria, 11 parts of Fructus Liquidambaris, 11 parts of Rhizoma Atractylodis, 9 parts of Rhizoma Cibotii, 14 parts of Radix Achyranthis Bidentatae, 9 parts of Rhizoma Alismatis, 12 parts of Herba Epimedii, withered luxuriant 12 parts of summer, 10 parts of the normal ministers in ancient times of Xu, 13 parts of Radix Clematidis, 15 parts of Scindapsus aureus.
Embodiment 2: the Chinese medicine composition according to present embodiment is formed by following bulk drugs compatibility: 8 parts of Rhizoma Chuanxiongs, 9 parts of Radix Angelicae Sinensis, 10 parts in Radix Notoginseng, 18 parts in Poria, 14 parts of Fructus Liquidambaris, 11 parts of Rhizoma Atractylodis, 9 parts of Rhizoma Cibotii, 11 parts of Radix Achyranthis Bidentatae, 9 parts of Rhizoma Alismatis, 14 parts of Herba Epimedii, withered luxuriant 13 parts of summer, 9 parts of the normal ministers in ancient times of Xu, 11 parts of Radix Clematidis, 12 parts of Scindapsus aureus.
Embodiment 3: the Chinese medicine composition according to present embodiment is formed by following bulk drugs compatibility: 6 parts of Rhizoma Chuanxiongs, 12 parts of Radix Angelicae Sinensis, 8 parts in Radix Notoginseng, 25 parts in Poria, 8 parts of Fructus Liquidambaris, 20 parts of Rhizoma Atractylodis, 5 parts of Rhizoma Cibotii, 35 parts of Radix Achyranthis Bidentatae, 6 parts of Rhizoma Alismatis, 20 parts of Herba Epimedii, withered luxuriant 13 parts of summer, 12 parts of the normal ministers in ancient times of Xu, 8 parts of Radix Clematidis, 20 parts of Scindapsus aureus.
During use, will cross 200 mesh sieves after the pulverizing medicinal materials of the crude drug of embodiment 1-3, pack into No. 0 or No. 1 capsule makes the rheumatism acesodyne capsule, in two kinds of capsules, the content of Chinese medicine composition is 0.35～0.40 gram/grain.Instructions of taking is one day three times, one time 2～3.
300 routine rheumatic and rheumatoid patients are divided into three groups at random, and every group 100 example taken above-mentioned 1, the 2 and No. 3 rheumatism acesodyne capsule that makes respectively.Judge therapeutic effect by following standard:
Significantly show as: arthralgia, symptom such as swell and ache comparatively fast alleviates; Healing shows as: arthralgia at first, and symptom such as swell and ache comparatively fast alleviates, and odd-shaped affected part is recovered normal and final gradually and is cured.
After one month, take the medicine group of embodiment 1, produce effects 100 examples, obvious effective rate 100%, cure rate 100%; Take the medicine group of embodiment 2, produce effects 100 examples, obvious effective rate 100% is cured 90 examples, cure rate 90%; Take the medicine group of embodiment 3, produce effects 100 examples, obvious effective rate 100% is cured 92 examples, cure rate 92%.No. 1 of embodiment 1 to 3 gained, No. 2 and No. 3 rheumatism acesodyne capsules have all shown extraordinary therapeutic effect, and No. 1 rheumatism acesodyne capsule with embodiment 1 is the best especially, and period in a medicine does not have any discomfort.
Through the clinical practice in 1 year by a definite date, No. 1 rheumatism acesodyne capsule that will have embodiment 1 prescription is treated routine rheumatic and rheumatoid patient surplus 120, rheumatic sufferers more than 90% was cured in one month fully, got well, and all the other rheumatic sufferers were cured after 40～50 days.
Typical case is as follows:
Case 1: Huang, woman, Teachers in Middle Schools, retirement.Lumbar vertebra is injured in the time of on the basketabll team, and normal pain is controlled repeatly and do not healed, and takes No. 1 rheumatism acesodyne capsule medicine continuously after one month, cures.
Case 2: Zhang, the woman, the waist knee joint is injured many years ago, and that controls does not heal, and the pain in the lumbar region of formation when producing is arranged again, can only lie in bed when serious, takes No. 1 rheumatism acesodyne capsule medicine continuously after one month, cures.
Case 3: Mrs Dai, before 9 years with the husband when factory is done in Yunnan, day heat is relieved summer heat and being attacked by dampness at intermountain bubbly water foot, the right knee joint soreness in back can not be worked, and obeys No. 1 rheumatism acesodyne capsule continuously and promptly heals after 10 days.
As mentioned above, we are illustrated according to aim of the present invention fully, but the present invention is not limited to the foregoing description and implementation method.The practitioner of correlative technology field can carry out different variations and implement the foregoing description only being explanation technical conceive of the present invention and characteristics in the scope of technological thought permission of the present invention; its purpose is to allow the personage who is familiar with this technology can understand content of the present invention and enforcement according to this, can not limit protection scope of the present invention with this.All equivalences that spirit is done according to the present invention change or modify, and all should be encompassed within protection scope of the present invention
Claims (7)
1. Chinese medicine composition, it is characterized in that: described Chinese medicine composition is made by following bulk drugs compatibility: 5～20 parts of Rhizoma Chuanxiongs, 5～20 parts of Radix Angelicae Sinensis, 5～20 parts in Radix Notoginseng, 5～30 parts in Poria, 5～30 parts of Fructus Liquidambaris, 5～30 parts of Rhizoma Atractylodis, 5～30 parts of Rhizoma Cibotii, 5～40 parts of Radix Achyranthis Bidentatae, 5～20 parts of Rhizoma Alismatis, 5～25 parts of Herba Epimedii, withered luxuriant 5～30 parts of summer, 5～25 parts of the normal ministers in ancient times of Xu, 5～30 parts of Radix Clematidis, 5～25 parts of Scindapsus aureus.
2. Chinese medicine composition according to claim 1 is characterized in that: described Chinese medicine composition is made by following bulk drugs compatibility: 8～10 parts of Rhizoma Chuanxiongs, 8～10 parts of Radix Angelicae Sinensis, 8～10 parts in Radix Notoginseng, 10～20 parts in Poria, 10～15 parts of Fructus Liquidambaris, 10～15 parts of Rhizoma Atractylodis, 8～10 parts of Rhizoma Cibotii, 10～20 parts of Radix Achyranthis Bidentatae, 8～10 parts of Rhizoma Alismatis, 10～15 parts of Herba Epimedii, withered luxuriant 10～15 parts of summer, 8～12 parts of the normal ministers in ancient times of Xu, 10～15 parts of Radix Clematidis, 10～20 parts of Scindapsus aureus.
3. Chinese medicine composition according to claim 2 is characterized in that: described Chinese medicine composition is made by following bulk drugs compatibility: 9 parts of Rhizoma Chuanxiongs, 9 parts of Radix Angelicae Sinensis, 9 parts in Radix Notoginseng, 15 parts in Poria, 11 parts of Fructus Liquidambaris, 11 parts of Rhizoma Atractylodis, 9 parts of Rhizoma Cibotii, 14 parts of Radix Achyranthis Bidentatae, 9 parts of Rhizoma Alismatis, 12 parts of Herba Epimedii, withered luxuriant 12 parts of summer, 10 parts of the normal ministers in ancient times of Xu, 13 parts of Radix Clematidis, 15 parts of Scindapsus aureus.
4. Chinese medicine composition according to claim 1 is characterized in that: in the described crude drug, weight such as Rhizoma Chuanxiong, Radix Angelicae Sinensis, Radix Notoginseng, Rhizoma Alismatis and Rhizoma Cibotii are used.
One kind as the described Chinese medicine composition of each claim in the claim 1 to 4 in the purposes of preparation in the antirheumatic pain relieving medicaments.
6. purposes according to claim 5 is characterized in that: described antirheumatic pain relieving medicaments is the medicine that is used for extremity rheumatalgia.
7. one kind by the rheumatism acesodyne capsule of making as the described Chinese medicine composition of each claim in the claim 1 to 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110176933A CN102228583B (en) | 2011-06-28 | 2011-06-28 | Chinese herbal composition and application thereof to preparing antirheumatic and antalgesic medicines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110176933A CN102228583B (en) | 2011-06-28 | 2011-06-28 | Chinese herbal composition and application thereof to preparing antirheumatic and antalgesic medicines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102228583A true CN102228583A (en) | 2011-11-02 |
| CN102228583B CN102228583B (en) | 2012-09-26 |
Family
ID=44841215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110176933A Expired - Fee Related CN102228583B (en) | 2011-06-28 | 2011-06-28 | Chinese herbal composition and application thereof to preparing antirheumatic and antalgesic medicines |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102228583B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105250677A (en) * | 2015-11-25 | 2016-01-20 | 韦调才 | Medicated wine for preventing and treating rheumatism and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101129946A (en) * | 2007-09-17 | 2008-02-27 | 吴兴保 | Wet rheumatalgia-relieving plaster for traumatic injury and method of producing the same |
-
2011
- 2011-06-28 CN CN201110176933A patent/CN102228583B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101129946A (en) * | 2007-09-17 | 2008-02-27 | 吴兴保 | Wet rheumatalgia-relieving plaster for traumatic injury and method of producing the same |
Non-Patent Citations (1)
| Title |
|---|
| 汪悦: "五积散的临床运用", 《南京中医药大学学报》, vol. 11, no. 05, 30 September 1995 (1995-09-30), pages 17 - 18 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105250677A (en) * | 2015-11-25 | 2016-01-20 | 韦调才 | Medicated wine for preventing and treating rheumatism and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102228583B (en) | 2012-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102309644B (en) | Traditional Chinese medical composition for treating bone fracture | |
| CN103156972B (en) | Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury | |
| CN101766773B (en) | Chinese medicine prescription for treating talagia | |
| CN102895460B (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
| CN103417742A (en) | Traditional Chinese medicine for curing cervical spondylosis and lumbar intervertebral disc hernia | |
| CN1970045B (en) | Externally applied Chinese medicine for treating cervical and lumbar spondylosis | |
| CN103768315A (en) | Bone-setting plaster for setting bone and activating blood circulation | |
| CN103565969A (en) | Traditional Chinese medicine composition for treating soft tissue injury and fracture | |
| CN101721651B (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
| CN102512560B (en) | Traditional Chinese medicinal composition for treating arthromyodynia | |
| CN102018821B (en) | Chinese medicament for treating hypertrophic rachitis | |
| CN102228583B (en) | Chinese herbal composition and application thereof to preparing antirheumatic and antalgesic medicines | |
| CN104013827A (en) | Traditional Chinese medicine preparation for treating hemiparalysis | |
| CN106139015A (en) | A kind of Chinese medicine composition treating neck-shoulder pain, lumbago and leg pain | |
| CN102441131A (en) | Chinese medicinal composition for treating traumatic injury | |
| CN104940863A (en) | Medical dressing paste for treating sciatica | |
| CN104524080A (en) | Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method | |
| CN104258285A (en) | Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof | |
| CN109806351A (en) | Neck-shoulder pain, lumbago and leg pain temperature, which is applied, to be dissipated | |
| CN103083489B (en) | Traditional Chinese medicine wine for treating lumbar spondylosis, cervical spondylosis, early osteoproliferation and old wounds | |
| CN103550319B (en) | Outer application preparation for treating knee athletic injury and preparation method thereof | |
| CN100512867C (en) | Traditional Chinese medicinal preparation for treating rheumatic arthritis, rheumatoid oarthritis, intervertebral disc and ischialgia neuralgia | |
| CN102028887B (en) | Traditional Chinese medicine for treating hyperplasia of cervical vertebra | |
| CN105079690A (en) | External used Wenshu moxibustion patch for treating osseous rheumatism | |
| CN104606428A (en) | Traditional Chinese medicine spray for treating temporomandibular joint diseases and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120926 Termination date: 20160628 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |